Oral GLP-1 Drug May Simplify Diabetes Treatment

[ad_1]

(MedPage Today) — At the American Diabetes Association annual meeting, results from the ACHIEVE-5 trial showed that adding oral orforglipron (Foundayo) to basal insulin significantly improved glycemic control, reduced body weight, and limited…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/adavideopearls/122061

Author :

Publish date : 2026-07-06 16:45:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version